Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors
A. Dubois, Pascale Bellaud, Marine Seffals, Bruno Turlin, Alain Fautrel, Gabriel Ichim, Michel Rivoire, Guillaume Passot, Zuzana Macek Jílková, Thomas Decaens, Alain Viari, Barbara Testoni, Sandra Rebouissou, Josep M. Llovet, Fabien Zoulim, Romain Parent, Charlotte A. Hernandez, Claire Verzeroli, Armando Andres Roca Suarez, Abud-José Farca-Luna, Laurie Tonon, Roger Esteban-Fabró, Roser Pinyol, Marie‐Laure Plissonnier, Ievgeniia Chicherova (2024). Hepatocellular carcinoma hosts cholinergic neural cells and tumoral hepatocytes harboring targetable muscarinic receptors. , 7(1), DOI: https://doi.org/10.1016/j.jhepr.2024.101245.
Article287 days ago2693MO COTESARC: A multicentre, open-label, phase I-II evaluating the combination of MEK and PDL-1 inhibitors in patients with advanced soft tissue sarcoma (STS)
A. Dufresne, M. Brahmi, Claire Cropet, R. Bahleda, Sarah Watson, P. Pautier, I.L. Ray-Coquard, Isabelle Aerts, Axel Le Cesne, Anne Sophie Defachelles, F. Duffaud, G. Garin, M. Bernardin, Cécile Guichard, Laurie Tonon, Cyril Dégletagne, Bertrand Dubois, David Pérol, Jean Yves Blay, N. Corradini (2025). 2693MO COTESARC: A multicentre, open-label, phase I-II evaluating the combination of MEK and PDL-1 inhibitors in patients with advanced soft tissue sarcoma (STS). , 36, DOI: https://doi.org/10.1016/j.annonc.2025.08.3304.
Article18 days agoInvestigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
A. Dufresne, Shibani Pokras, A. Meurgey, Sylvie Chabaud, Maud Toulmonde, Emmanuelle Bompas, Axel Le Cesne, Y Robin, Florence Duffaud, Thibaud Valentin, Sophie El Zein, A. Leroux, Pascale Dubray‐Longeras, Nelly Firmin, Gonzague de Pinieux, Sabine Noal, Christophe Delfour, J. Bollard, Laurie Tonon, Agnes Hernández Biette, Nicolas Gadot, Valéry Attignon, Myriam Jean‐Denis, Mary Woessner, Erika Klohe, T. Thayaparan, Ioanna Eleftheriadou, Kristin Blouch, Michael J. Nathenson, Jean Yves Blay (2024). Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma. , 9(8), DOI: https://doi.org/10.1016/j.esmoop.2024.103645.
Article18 days agoAdded value of whole‐exome and <scp>RNA</scp> sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel
Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, Séverine Tabone‐Eglinger, Philippe A. Cassier, Olivier Trédan, Nadège Corradini, Armelle Vinceneux, Aurélie Swalduz, Alain Viari, Sylvie Chabaud, David Pérol, Jean Yves Blay, Pierre Saintigny (2024). Added value of whole‐exome and <scp>RNA</scp> sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. , 13(7), DOI: https://doi.org/10.1002/cam4.7115.
Article18 days agoAdded value of whole‐exome and <scp>RNA</scp> sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel
Armelle Dufresne, Valéry Attignon, Anthony Ferrari, Laurie Tonon, Sandrine Boyault, Séverine Tabone‐Eglinger, Philippe A. Cassier, Olivier Trédan, Nadège Corradini, Armelle Vinceneux, Aurélie Swalduz, Alain Viari, Sylvie Chabaud, David Pérol, Jean Yves Blay, Pierre Saintigny (2024). Added value of whole‐exome and <scp>RNA</scp> sequencing in advanced and refractory cancer patients with no molecular‐based treatment recommendation based on a 90‐gene panel. , 13(7), DOI: https://doi.org/10.1002/cam4.7115.
Article18 days ago